Interim Results of a Phase I Risk-Stratified Dose Escalation Study using Hypofractionated Helical Tomotherapy for Non-small Cell Lung Cancer

被引：0
|
作者：
Cannon, D. [1 ]
Adkison, J. B. [1 ]
Chappell, R. J. [1 ]
Perumal, K. [1 ]
Khuntia, D. [1 ]
Tome, W. A. [1 ]
Bentzen, S. M. [1 ]
Cannon, G. M. [1 ]
Tolakanahalli, R. [1 ]
Mehta, M. P. [1 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2010.07.277
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S107 / S108
页数：2
相关论文
共 50 条
  • [41] Vorinostat in combination with gemcitabine and cisplatinum in patients with advanced non-small cell lung cancer (NSCLC): A Phase I dose-escalation study
    Tredaniel, J.
    Descourt, R.
    Moro-Sibilot, D.
    Misset, J.
    Gachard, E.
    Garcia-Vargas, J.
    Roben, E.
    Zalcman, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [42] Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer
    Contreras, Jessika
    Srivastava, Amar
    Samson, Pamela
    DeWees, Todd
    Govindan, Ramaswamy
    Baggstrom, Maria Q.
    Morgensztern, Daniel
    Roach, Michael
    Badiyan, Shahed N.
    Bradley, Jeffrey
    Waqar, Saiama
    Robinson, Clifford
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 113 (04): : 742 - 748
  • [43] Preliminary results from a phase I dose escalation trial of limited field hypofractionated thoracic radiotherapy for limited stage small cell lung cancer
    Yee, D.
    Chu, Q.
    Butts, C.
    Joy, A.
    Fenton, D.
    Smylie, M.
    Reiman, A.
    Roa, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S458 - S459
  • [44] Phase I/II Dose Escalation Study of L-DOS47 as a Monotherapy in Non-Squamous Non-Small Cell Lung Cancer Patients
    Ramlau, Rodryg
    Kowalski, Dariusz
    Szczylik, Cezary
    Szczegsna, Aleksandra
    Wiatr, Elzbieta
    Demas, Steve
    Chao, Heman
    Roszkowski-Sliz, Kazimierz
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1071 - S1072
  • [45] Oral vinorelbine concomitantly with thoracic radiotherapy (RT) in locally-advanced or inoperable stage III non-small cell lung cancer (NSCLC): interim results of a phase I dose escalation trial
    Krzakowski, M.
    Gridelli, C.
    Paccagnella, A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 382 - 383
  • [46] Paclitaxel and carboplatin in metastatic non-small cell lung cancer: Preliminary results of a phase I study
    Belani, CP
    Aisner, J
    Hiponia, D
    Ramanathan, R
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 19 - 21
  • [47] Phase I dose escalation study of the protein kinase C iota inhibitor aurothiomalate for advanced non-small cell lung cancer, ovarian cancer, and pancreatic cancer
    Mansfield, Aaron Scott
    Fields, Alan P.
    Jatoi, Aminah
    Qi, Yingwei
    Adjei, Alex A.
    Erlichman, Charles
    Molina, Julian R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [48] Phase I study of erlotinib and hydroxychloroquine in non-small cell lung cancer
    Sequist, Lecia, V
    Sharma, Sreenath, V
    Supko, Jeffrey G.
    Neal, Joel W.
    Fidias, Panos
    Temel, Jennifer
    Heist, Suk Rebecca
    Shaw, Alice T.
    Engelman, Jeffrey A.
    Settleman, Jeffrey E.
    Lynch, Thomas J.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S712 - S713
  • [49] A phase I study of gemcitabine and carboplatin in non-small cell lung cancer
    Carmichael, J
    Allerheiligen, S
    Walling, J
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 55 - 59
  • [50] A dose-escalation study of vorinostat in combination with radiotherapy for patients with non-small cell lung cancer
    Decker, R. H.
    Gettinger, S. N.
    Wilson, L. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345